Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
obesity drugs
Pharma
Novo, Lilly obesity meds 'highly cost-effective': ICER report
ICER has high confidence in the drugs' cost-effectiveness but also voiced concerns over the drugs' impact on healthcare budgets.
Eric Sagonowsky
Sep 9, 2025 10:30am
Lilly links up with JD Health for DTC drug sales in China
Aug 29, 2025 10:20am
Roche breaks ground on $700M N.C. manufacturing site
Aug 28, 2025 9:35am
Currax cranks up Contrave campaigns, taking obesity ad national
Aug 5, 2025 12:00pm
China biotech deals, Takeda, LaNova—Fierce Pharma Asia
Jul 18, 2025 9:04am
Lilly, Innovent's mazdutide nabs first-in-class nod in China
Jun 27, 2025 11:16am
